Burning Rock Biotech
BNR
41 hedge funds and large institutions have $49.5M invested in Burning Rock Biotech in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 19 reducing their positions, and 18 closing their positions.
1.3% less ownership
Funds ownership: 22.12% → 20.82% (-1.3%)
21% less funds holding
Funds holding: 52 → 41 (-11)
25% less capital inflows, than outflows
Capital inflows: $8.7M | Capital outflows: $11.6M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
56% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 18
63% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$6.41M |
| 2 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$1.57M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$150K |
| 4 |
Goldman Sachs
New York
|
+$126K |
| 5 |
HRT Financial
New York
|
+$53.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.44M |
| 2 |
OrbiMed
New York
|
-$3.07M |
| 3 |
Millennium Management
New York
|
-$595K |
| 4 |
State Street
Boston,
Massachusetts
|
-$571K |
| 5 |
Barclays
London,
United Kingdom
|
-$521K |
BNR Hedge Fund Activity: Q4 2022 in Review
41 of the 6,244 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q4 2022, worth a combined $49.5M — down 11% from $55.5M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of BNR and 8 opened new positions — a net loss of 10 holders — while 19 trimmed existing stakes and 7 added.
The largest buyer was Fidelity International, opening a new position worth an estimated $6.41M. The largest seller was BlackRock, cutting an estimated $3.44M.
- 41 institutional investors held Burning Rock Biotech (BNR) as of Q4 2022, down from 52 in Q3 2022.
- Funds reported $49.5M of Burning Rock Biotech stock for Q4 2022, down 11% quarter-over-quarter.
- 8 funds opened new Burning Rock Biotech positions in Q4 2022 and 18 closed out, a net change of -10 holders.
- The largest Burning Rock Biotech buyer in Q4 2022 was Fidelity International, an estimated $6.41M added.
- The largest Burning Rock Biotech seller in Q4 2022 was BlackRock, an estimated $3.44M sold.
Based on aggregated 13F filings for Q4 2022.